Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (201-210 of 1,315) with videos related to

Pageof 132
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 28, 2021
Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of BiologicsLaura Cacciaguerra, Paola Tortorella, Maria A Rocca, et al.
Nature Clinical Practice. Neurology|November 6, 2007
The effect of white matter lesions on cognition in the elderly--small but detectableGiovanni B Frisoni, Samantha Galluzzi, Leonardo Pantoni, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Neurology and Therapy|April 10, 2026
Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future PerspectivesPaolo Preziosa, Giorgio Guido, Massimo Filippi, et al.
Journal of Neurology|July 11, 2020
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implicationsStefano Gelibter, Lucia Moiola, Stefano Carlo Previtali, et al.
Journal of Neurology|May 1, 2024
Advanced neuroimaging techniques to explore the effects of motor and cognitive rehabilitation in multiple sclerosisMaria A Rocca, Francesco Romanò, Nicolò Tedone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 6, 2022
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal studyIlaria Cetta, Roberta Messina, Laura Zanandrea, et al.
The Lancet. Neurology|June 21, 2020
COVID-19: can we learn from encephalitis lethargica?Antonino Giordano, Ghil Schwarz, Laura Cacciaguerra, et al.
Journal of Neurology|December 13, 2022
Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI reviewMichela Leocadi, Elisa Canu, Angela Paldino, et al.
Statistics in Medicine|August 1, 2013
pFDR and pFNR estimation for brain networks constructionSara Sala, Piero Quatto, Paola Valsasina, et al.
Pageof 132

Showing results (201-210 of 1,315) with videos related to

Sort By:
Pageof 132
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 28, 2021
Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of BiologicsLaura Cacciaguerra, Paola Tortorella, Maria A Rocca, et al.
Nature Clinical Practice. Neurology|November 6, 2007
The effect of white matter lesions on cognition in the elderly--small but detectableGiovanni B Frisoni, Samantha Galluzzi, Leonardo Pantoni, et al.
Neurology|February 13, 2002
MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patientsMaria Pia Sormani, Paolo Bruzzi, Giancarlo Comi, et al.
Neurology and Therapy|April 10, 2026
Treatment Effects on Chronic Active Lesions in Multiple Sclerosis: Current Evidence and Future PerspectivesPaolo Preziosa, Giorgio Guido, Massimo Filippi, et al.
Journal of Neurology|July 11, 2020
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implicationsStefano Gelibter, Lucia Moiola, Stefano Carlo Previtali, et al.
Journal of Neurology|May 1, 2024
Advanced neuroimaging techniques to explore the effects of motor and cognitive rehabilitation in multiple sclerosisMaria A Rocca, Francesco Romanò, Nicolò Tedone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 6, 2022
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal studyIlaria Cetta, Roberta Messina, Laura Zanandrea, et al.
The Lancet. Neurology|June 21, 2020
COVID-19: can we learn from encephalitis lethargica?Antonino Giordano, Ghil Schwarz, Laura Cacciaguerra, et al.
Journal of Neurology|December 13, 2022
Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI reviewMichela Leocadi, Elisa Canu, Angela Paldino, et al.
Statistics in Medicine|August 1, 2013
pFDR and pFNR estimation for brain networks constructionSara Sala, Piero Quatto, Paola Valsasina, et al.
Pageof 132